February 5, 2025 A New Wave of Therapeutic Innovation Through Targeting Transcription Factors From the Trenches Read more
January 13, 2025 Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal Portfolio Company News Read more
December 11, 2024 Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic Portfolio Company News Read more